PRESS RELEASE published on 05/12/2023 at 23:45, 2 years 10 months ago Relief Therapeutics Has Filed its 2022 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
PRESS RELEASE published on 05/03/2023 at 07:00, 2 years 10 months ago Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares
PRESS RELEASE published on 05/01/2023 at 07:00, 2 years 10 months ago Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA™ Commercial Launch Progressing Ahead of Schedule
PRESS RELEASE published on 04/28/2023 at 19:00, 2 years 10 months ago Relief Therapeutics Announces Results of Extraordinary General Meeting of Shareholders
PRESS RELEASE published on 04/17/2023 at 07:00, 2 years 11 months ago Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
PRESS RELEASE published on 04/14/2023 at 07:00, 2 years 11 months ago Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update
PRESS RELEASE published on 04/05/2023 at 07:00, 2 years 11 months ago Relief Therapeutics Announces Executive Leadership Team Change
PRESS RELEASE published on 04/04/2023 at 07:00, 2 years 11 months ago Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders
PRESS RELEASE published on 04/03/2023 at 07:00, 2 years 11 months ago Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board
PRESS RELEASE published on 03/22/2023 at 07:00, 3 years ago Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023
Published on 03/27/2026 at 12:30, 3 hours 9 minutes ago Pasinex Closes First Tranche of Over-Subscribed Non-Brokered Private Placement
Published on 03/27/2026 at 12:00, 3 hours 39 minutes ago Temas Appoints Scientific Advisory Board to Accelerate RCL Commercialisation and Global Development
Published on 03/27/2026 at 11:00, 4 hours 39 minutes ago RE Royalties Announces Strategic Review to Evaluate Path for Long-Term Value Creation
Published on 03/27/2026 at 09:30, 6 hours 9 minutes ago Amap Street Stars Launches Macao Authentic Delicacies Ranking to Drive Cultural-Tourism Innovation in the Greater Bay Area
Published on 03/27/2026 at 15:05, 34 minutes ago Huawei's 6th Global Installer Summit: Gathering the Best Installers to Embrace Renewable Energy Opportunities in the AI Era
Published on 03/27/2026 at 14:31, 1 hour 8 minutes ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 03/27/2026 at 14:30, 1 hour 9 minutes ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 03/27/2026 at 14:29, 1 hour 10 minutes ago Form 8.3 - The Vanguard Group, Inc.: AEW UK REIT plc
Published on 03/27/2026 at 07:00, 8 hours 39 minutes ago WEB SA - CONVOCATION ASSEMBLEE GENERALE ORDINAIRE EXERCICE 2025 - 28/04/2026
Published on 03/26/2026 at 18:17, 21 hours 22 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 21 hours 22 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 21 hours 39 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
